On September 1, 2021 Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, reported that members of its senior management team will participate in the following September investor conferences (Press release, Prothena, SEP 1, 2021, View Source [SID1234587187]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual BioPharma Virtual Conference on Wednesday, September 8, a fireside chat will be held at 9:45 AM ET and a panel discussion titled "What’s Next for Neurodegenerative Diseases" will be held at 11:35 AM ET
H.C. Wainwright 23rd Annual Global Investment Conference, on Monday, September 13, a fireside chat will be available on demand starting at 7:00 AM ET
Cantor Global Healthcare Conference on Monday, September 27, a fireside chat will be held at 11:20 AM ET
A live webcast for all events can be accessed through the investor relations section of the Company’s website at www.prothena.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for at least 90 days following the presentation date.